A recent study has demonstrated the safety and efficacy of bulevirtide (BLV) monotherapy for 48 weeks in difficult-to-treat patients with hepatitis delta virus (HDV)-related compensated cirrhosis and clinically significant portal hypertension (CSPH).
Patients on antifibrotics experience chest wall dehiscence earlier than those who did not receive antifibrotic treatment following lung transplantation, reveals a recent study, noting that this factor does not significantly influence survival.
Breast cancer patients with a more trustful bond with their physicians appear to be more open to taking adjuvant endocrine therapy (AET) and show lower concerns regarding the treatment, a recent study has found.
In the treatment of patients with multivessel coronary artery disease, percutaneous coronary intervention (PCI) with everolimus-eluting stents appears to yield similar outcomes in terms of the incidence of major adverse cardiac events, the composite safety endpoint, and all-cause mortality, according to the results of the BEST trial.
The use of alprazolam leads to rapid termination of seizures in patients with focal and/or generalized epilepsy treated in an inpatient setting, according to the results of the phase II study ENGAGE-E-001.